Estimates Revisions DexCom, Inc.
Stocks
DXCM
US2521311074
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
After hours 07:56:45 pm | |||
| 71.23 USD | -2.64% |
|
71.21 | -0.03% |
| Jun. 16 | AI Can Play 'Significant' Role in Tech for Managing Diabetes, Says David Roman | MT |
| Jun. 15 | Piper Sandler Adjusts Price Target on DexCom to $88 From $75, Maintains Overweight Rating | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | - | ||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- DXCM Stock
- Consensus DexCom, Inc.
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
